Leukodepletion for patients undergoing heart valve surgery
References
Additional references
Alexiou C, Sheppard S, Tang A, Rengarajan A, Smith D, Haw M, Gibbs R. Leukocytes‐depleting filters preferentially remove activated leukocytes and reduce the expression of surface adhesion molecules during the simulated extracorporeal circulation of human blood.. American Society for Artificial Internal Organs Journal 2006;52:438‐444.
Allen S. The role of leucocytes in the systemic inflammatory response and the potential impact of leucocyte depletion. Cardiovasc Eng 1997;2:34‐54.
Antunes PE, Prieto D, Ferrao de Oliveira J, Antunes MJ. Renal dysfunction after myocardial revascularization. European Journal of Cardiothoracic Surgery 2004;25:597‐604.
Baberg HT, Dirlich M, Laczkovics A, Grewe P, Bojara W, de Zeeuw J, Bauer TT, Kugler J, Mugge A. Determinants of health‐related quality of life after aortic valve replacement in six‐month survivors of intervention. Journal of Heart Valve Disease 2004;13(6):914‐20.
Bando K, Pillai R, Cameron DE, Brawn JD, Winkelstein JA, Hutchins GM, Reitz BA, Baumgartner WA. Leucocyte depletion ameliorates free radical mediated lung injury after cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery 1990;99(5):873‐7.
Bando K, Schueler S, Cameron DE, DeValeria PA, Hatanaka M, Casale AS, Zebley MA, Hutchins GM, Reitz BA, Baumgartner WA. Twelve‐hour cardiopulmonary preservation using donor core cooling, leucocyte depletion, and liposomal superoxide dismutase. Journal of Heart and Lung Transplantation 1991;10(2):304‐9.
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure ‐ definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 2004;8(4):R204. [DOI: 10.1186/cc2872]
Bennet SJ, Oldridge NB, Eckert GJ, Embree JL, Browning S, Hou N, Deer M, Murray MD. Discriminant properties of commonly used quality of life measures in heart failure. Quality of Life Research 2002;11(4):349‐59.
Blumenthal JA, Mank DB. Quality of life and recovery after cardiac surgery. Psychosomatic Medicine 1994;56(3):213‐15.
Bolcal C, Akay HT, Bingol H, Doganci S, Yildirim V, Yenicesu M, Demirkilic U, Tatar H. Leukodepletion improves renal function in patients with renal dysfunction undergoing on‐pump coronary bypass surgery:a prospective randomised study. The Thoracic and Cardiovascular Surgeon 2007;55(2):89‐93.
Brown JM, O'Brien SM, Wu C, Sikora JH, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. Journal of Thoracic and Cardiovascular Surgery 2009;137:82‐90.
Brown JR, Kramer RS, Coca SG, Parikh CR. Duration of acute kidney injury impacts long‐term survival after cardiac surgery. Annals of Thoracic Surgery 2010;90(4):1142‐1148.
Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:552‐98.
Caine N, Harrison SC, Sharples LD, Wallwork J. Prospective study of quality of quality of life before and after coronary artery bypass grafting.. British Medical Journal 1991;302(6775):511‐16.
Conlon PJ, Stafford‐Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K. Acute renal failure following cardiac surgery. Nephrology Dialysis Transplantation 1999;14:1158‐1162.
Dasta JF, Kane‐Gill SL, Durtschi AJ, Pathak DS, Kellum JA. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008;23(6):1970‐1974.
Dunning J, Gao H, Chambers J, Moat N, Murphy G, Pagano D, Ray S, Roxburgh J, Bridgewater B. Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use ‐ an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database. Journal of Thoracic and Cardiovascular Surgery 2011;142:776‐782.
Efstathiou A, Vlachveis M, Tsonis G, Asteri T, Psarakis A, Fessatidis IT. Does leukodepletion during elective cardiac surgery really influence the overall clinical outcome?. Journal of Cardiovascular Surgery 2003;44(2):197‐204.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. British Medical Journal 1997;315((7109)):629‐34.
Fabbri A, Manfredi J, Piccin C, Soffiati G, Carta MR, Gasparotto E, Nardon G. Systemic leucocyte filtration during cardiopulmonary bypass. Perfusion 2001;16(1):11‐18.
Falcoz PE, Chocron S, Stoica L, Kaili D, Puyraveau M, Mercier M, Etievent JP. Open heart surgery: one‐year self‐assessment of quality of life and functional outcome. Annals of Thoracic Surgery 2003;76(5):1598‐604.
Gott JP. Leucodepletion and aprotinin improve clinical outcome after extracorporeal circulation. Perfusion 2001;S16:5‐9.
Gourlay T, Fleming J, Taylor KM. Laboratory evaluation of the Pall LG6 leukocyte depleting arterial line filter. Perfusion 1992;7:131‐140.
Gourlay T, Fleming J, Taylor KM. The effects of pulsatile flow on the leukocyte depleting qualities of the Pall LG6 leukocyte depleting arterial line filter: a laboratory investigation. Perfusion 1992;7(3):227‐32.
Grayson AD, Khater M, Jackson M, Fox MA. Valvular heart operation is an independent risk factor for acute renal failure.. Annals of Thoracic Surgery 2003;75(6):1829‐35.
Gu YJ, de Vries AJ, Boonstra PW, van Oeveren W. Leucocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. Journal of Thoracic and Cardiovascular Surgery 1996;112(2):494‐500.
Gu YJ, de Vries AJ, Vos P, Boonstra PW, van Oeveren W. Leucocyte depletion during cardiac operation: a new approach through the venous bypass circuit.. Annals of Thoracic Surgery 1999;67(3):604‐9.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hunt IJ, Day JRS. Cardiac surgery and inflammation. Current Cardiac Reviews 2007;3(1):91‐8.
International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR & ICH Guidelines. USA: Barnett International/PAREXEL, 1997; Vol. 1.
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke‐Barwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. European Heart Journal 2003;24(13):1231‐1243.
Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nature Reviews Cardiology 2011;8:162‐172.
Juergens MC, Seekatz B, Moosdorf RG, Petrie KJ, Rief W. Illness beliefs before cardiac surgery predict disability, quality of life and depression 3 months later. Journal of Psychosomatic Research 2010;68(6):553‐60.
Kirklin JK. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 1991;51:529‐31.
Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.
Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Annals of Internal Medicine 1998;128:194‐203.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Cre 2007;11(2):R31. [DOI: 10.1186/cc5713]
Morris SJ. Leucocyte reduction in cardiovascular surgery. Perfusion 2001;16:371‐80.
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez‐Sarano M. Burden of valvular heart diseases: a population based study. Lancet 2006;368:1005‐1011.
Palanzo D, Manley N, Montesano R, Yeisley G, Gordon D. Clinical evaluation of the LeukoGuard (LG‐6) arterial line filter for routine open‐heart surgery. Perfusion 1993;8:489‐96.
Papadopoulou EF, Mavrogeni SI, Dritsas A, Cokkinos DV. Assessment of quality of life using three activity questionnaires in heart failure patients after monthly, intermittent administration of levosimendan during a six‐month period. Hellenic Journal of Cardiology 2009;50(4):269‐74.
Pedersen SS, Versteeg H, Denollet J, Cheng JM, Serruys PW, van Domburg RT. Patient‐rated health status predicts prognosis following percutaneous coronary intervention with drug‐eluting stenting. Quality of Life Research, Online First 2010;October.
Sawa Y, Matsuda H, Shimazaki Y, Kaneko M, Nishimura M, Amemiya A, Sakai K, Nakano S. Evaluation of leucocyte‐depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery 1994;108(6):1125‐31.
Schueler S, DeValeria PA, Hatanaka M, Cameron DE, Bando K, Zebley MA, Hutchins GM, Reitz BA, Baumgartner WA. Successful twenty‐four‐hour lung preservation with donor core cooling and leucocyte depletion in an orthotopic double lung transplantation model.. Journal of Thoracic and Cardiovascular Surgery 1992;104(1):73‐82.
Soler‐Soler J, Galve E. Worldwide perspective of valve disease. Heart 2000;83:721‐725.
Sutton SW, Patel AN, Chase VA, Schmidt LA, Hunley EK, Yancey LW, Hebeler RF, Cheung EH, Henry AC, Meyers TP, Wood RE. Clinical benefits of continuous leucocyte filtration during cardiopulmonary bypass in patients undergoing valvular repair or replacement. Perfusion 2005;20:21‐29.
Taillefer MC, Dupuis G, Hardy JF, LeMay S. Quality of life before and after heart valve surgery is influenced by gender and type of valve. Quality of Life Research 2005;14(3):769‐78.
Tang AT, Alexiou C, Hsu J, Sheppard SV, Haw MP, Ohri SK. Leukodepletion reduced renal injury in coronary revascularisation: a prospective randomised study. Annals of Thoracic Surgery 2002;74(2):372‐7.
Thadhani R, Pascual M, Bonventre JV. Acute renal failure. New England Journal of Medicine 1996;334(22):1448‐1460.
Thurlow PJ, Doolan L, Sharp R, Sullivan M, Smith B, Andersen LW. Laboratory studies of the effect of Pall extracorporeal leucocyte filters LG6 and AV6 on patients undergoing coronary bypass grafts. Perfusion 1996;11(1):29‐37.
Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Lung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A. Guidelines on the management of valvular heart disease. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. European Heart Journal 2007;28:230‐268. [DOI: 10.1093/eurheartj/ehl428]
Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med 1987;13:89‐95.
